StonvexLoading…
StonvexStonvexStonvexCore line items from ACTG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $285.23M | $122.31M | $125.10M | $59.22M |
Operating Income | $6.41M | $-32.93M | $20.94M | $-40.09M |
Net Income | $21.68M | $-36.06M | $67.06M | $-125.06M |
EPS (Diluted) | $0.22 | $-0.36 | $0.58 | $-3.13 |
Total Assets | $770.96M | $756.39M | $633.54M | $482.93M |
Total Liabilities | $186.92M | $203.78M | $43.94M | $193.68M |
Cash & Equivalents | $306.72M | $273.88M | $340.09M | $287.79M |
Free Cash Flow OCF − CapEx | Not available | $-98.55M | $-22.70M | $-38.07M |
Shares Outstanding | 96.48M | 96.05M | 99.90M | 43.48M |